Advanced Optics Electronics Inc.'s COLOR-CHEK Aimed to Aid Dental Profession; Biomoda Inc. Adds Drs. Whitaker and Neft to Research Team.Business Editors ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Dec. 9, 2003 Advanced Optics Electronics Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ADOT ADOT Arizona Department Of Transportation ADOT Alaska Department of Transportation ADOT Fédération des Associations pour le Don d'Organes et de Tissus Humains ADOT Active Duty Other Than Training ADOT Automatic Digital Optical Tracker ADOT Advanced Display Optimization Tools ) reported that development of its unique COLOR-CHEK device has been expanded by adding an important focus as a low-priced device for the dental profession. In conjunction with this direction, the company has expanded its engineering department with additional staff personnel to work in pre-assembly and optical enhancement of specific key elements. Biomoda Inc. (of which ADOT directly and indirectly owns and controls 30 percent) confirmed that two additional research positions have been filled with the appointment of Dr. Herbert H. Whitaker and Dr. Robin Neft. Whitaker received his Ph.D. in chemical engineering from Virginia Polytech University and has had senior positions with Johnson & Johnson, G.E. and Dowbadische. Neft holds a Ph.D. from the University of Pittsburgh in Genetic Toxicology toxicology, study of poisons, or toxins, from the standpoint of detection, isolation, identification, and determination of their effects on the human body. Toxicology may be considered the branch of pharmacology devoted to the study of the poisonous effects of drugs. and has conducted research at Phase-1 Molecular Toxicology, Lovelace Respiratory Research Institute and with the U.S Government Agency for Toxic Substances and Disease Registry The United States Agency for Toxic Substances and Disease Registry, (ATSDR) is an agency for the U.S. Department of Health and Human Services that is directed by a congressional mandate to perform specific functions concerning the effect on public health of hazardous . Biomoda is set to confirm within 4-6 weeks at least two important research joint ventures with well-known research and health organizations. Areas of the joint ventures will concern themselves with clinical trials and staining staining /stain·ing/ (stan´ing) 1. artificial coloration of a substance to facilitate examination of tissues, microorganisms, or other cells under the microscope. For various techniques, see under stain. 2. procedures. Biomoda Inc. has scheduled the closing of its subscription books by weekend in anticipation of the presentation of the final elements of its initial preparatory listing on the OTC BB. Advanced Optics Electronics Inc. is a technology company based in Albuquerque, N.M. The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays A thin display screen for computer and TV usage. The first flat panels appeared on laptop computers in the mid-1980s, and the LCD technology became the standard. Stand-alone LCD screens became available for desktop computers in the mid-1990s and exceeded sales of CRTs for the first time utilizing its patented and patent-pending technology. In addition to the core business of ADOT, the company has made a strategic technology-oriented investment in Biomoda Inc. Biomoda Inc. is a company that holds patents and patents pending domestically and internationally for the early detection of lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . ADOT currently holds directly and indirectly 30 percent of Biomoda Inc. This news release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates," and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion